F
Five Prime Therapeutics
Innovative Protein Therapeutics
At a glance
- Status
- Listed
- Founded
- 2001
- Headquarters
- South San Francisco, United States
- Listing
- IPO 2013
- Sector
- Biotech & Life Sciences
- Power Law
- Unicorn$1–10B valuation tier
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later7 investors entered at this stage
- HEHealthCap
- WTWellcome Trust
Kleiner Perkins
Versant Ventures- AVAdvanced Technology Ventures
- DADomain Associates
- DCDiamond Capital Company
Source: Dealroom Talent Intelligence.
Alumni founders
Former Five Prime Therapeutics employees who went on to found companies, sorted by Dealroom signal score.
RARayzeBioEst. 2020
Deborah Charych, Ph.D.United States
NUNurixEst. 2012
Arthur WeissUnited States
CLCell Design LabsEst. 2015
Brian WongChinaGlobal footprint
Patents
51 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Five Prime Therapeutics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Five Prime Therapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.